May 17, 2020

Z-SC1 Biomedical: Why Hipsters Taking Over the Biotech Industry is a Good Thing

Biotech
Z-SC1 Biomedical
Biomedical
Freezer
Admin
4 min
Not only are hipsters greener and more ethical than the rest of us, but the industries in which they work are driving our economy.
Z-SC1 Biomedical Corp. is a Canadian-based company with a successful record of developing laboratory equipment for the biomedical and biotech industry...

Z-SC1 Biomedical Corp. is a Canadian-based company with a successful record of developing laboratory equipment for the biomedical and biotech industry.

Headquartered in Montreal, Canada with manufacturing bases in Seoul, South Korea, Z-SC1 Biomedical is revolutionizing the scientific community, and with it, the world.

“Being in the scientific community for 20 years, we have learned something special,” said Jean Fallacara, CEO of Z-SC1 Biomedical, in a recent interview. “The more you work closely with research and development, the more you try to represent the voice of the customer, is the way you plant a seed and remain a leader.”

Every company claims to have re-shaped the technology of the past to create better products, but at Z-SC1 Biomedical, that claim is true.

The biotech company is the first to have analyzed the industry, discovered a crucial dilemma and come up with the perfect solution: a Twincore ultra-low temperature freezer.

“We changed the world with the Twincore freezer technology,” said Fallacara.

The Safest, Ultra-Low Temp Freezer Around

The Twincore freezer is the first and only of its kind, featuring two independent compressor systems each capable of maintaining -82C. Its pull down and pull up times are remarkable as well as its energy efficiency.

Standard ultra-low temp freezers rely on a cascade refrigeration system. Meaning that if the system fails, the freezer and any samples stored inside have to removed in a couple of hours. LN2 or CO2 backups only sustain temperatures for approximately seven hours, and require routine re-filling, maintenance and supervision.

But aside from the impressive maintenance of temperature, every Twincore includes the WizBox monitoring system which adds peace of mind to your lab making the safest even safer. In addition to being an alarm system, it lets you manage your samples and inventory, history and events remotely.

Z-SC1 Biomedical is a sustainable company, and the Twincore freezer is proof of the company’s promise of staying green.

The freezer projects 75 percent less heat rejection than standard cascade refrigeration, is made from 85 percent recyclable material and 10 percent of that material can even be used to generate energy.

“We are one of the only manufacturers of freezers that stays with natural refrigeration gases,” said Fallacara. “Sustainability has been on my mind for many years. We try to reduce our operating costs by 25 percent along with reducing the water consumption in our industry.”

Why Is Everyone Talking About Z-SC1?

In short, it’s “sexy and cool.” At least this is exactly how Fallacara describes his company when talking about the culture and atmosphere.

“Honestly, our company has that image where people who look at our marketing tools, our communication, the way we act, find us to be different for the field we are in,” explained Fallacara. “Everyone who pictures the scientific community thinks of old scientists with white hair and white coats working in the lab. Here, in every single lab, there are young guys that ride a skateboard, like cars, like music and this is the way I want to project the image of our company.”

Aside from attracting young scientists who want to further grow the community, it’s pretty easy for Fallacara to retain his employees once they arrive at the company. And it’s all in his management style.

“For me, and for us, every interaction counts, and every individual matters. I don’t care much about corporate strategies – who’s the boss of who and things like that. What is really important is building relationships – creating motivation and empowerment where everyone is free to set their own targets, to perform and to work at the time they want the way they feel is best to do it,” added Fallacara.

[READ MORE] How To Make Regulatory Outsourcing Effective for Pharma, Biotech Industries

Fallacara aims to find talent in every employee at his company. He therefore believes that the management of a workforce is not very complicated because it’s not required.

“People are focused on their job; they want to perform,” he said. “And when they don’t perform by themselves, they ask for more advice on what they can do better and the team will then help them to succeed.”

Looking Ahead

The Twincore is only the first step in Z-SC1 Biomedical’s advancement and future plans. There are a number of new ideas and products set to be rolled out entering the new year.

“We want to keep the revolution going and change the whole industry where refrigeration is involved,” said Fallacara. “We’re still a small company compared to our main competitors (Panasonic and Turbo). So, I would like to see our company ranked where it is deserved, which means no less than the first row.”

Follow us on Twitter (@HealthcareGlbl) and like us on Facebook!

Share article

Jun 18, 2021

Skin Analytics wins NHSX award for AI skin cancer tool 

AI
NHS
skincancer
Cancer
2 min
Skin Analytics uses AI to detect skin cancer and will be deployed across the NHS to ease patient backlogs

An artificial intelligence-driven tool that identifies skin cancers has received an award from NHSX, the NHS England and Department of Health and Social Care's initiative to bring technology into the UK's national health system. 

NHSX has granted the Artificial Intelligence in Health and Care Award to DERM, an AI solution that can identify 11 types of skin lesion. 

Developed by Skin Analytics, DERM analyses images of skin lesions using algorithms. Within primary care, Skin Analytics will be used as an additional tool to help doctors with their decision making. 

In secondary care, it enables AI telehealth hubs to support dermatologists with triage, directing patients to the right next step. This will help speed up diagnosis, and patients with benign skin lesions can be identified earlier, redirecting them away from dermatology departments that are at full capacity due to the COVID-19 backlog. 

Cancer Research has called the impact of the pandemic on cancer services "devastating", with a 42% drop in the number of people starting cancer treatment after screening. 

DERM is already in use at University Hospitals Birmingham and Mid and South Essex Health & Care Partnership, where it has led to a significant reduction in unnecessary referrals to hospital.

Now NHSX have granted it the Phase 4 AI in Health and Care Award, making DERM available to clinicians across the country. Overall this award makes £140 million available over four years to accelerate the use of artificial intelligence technologies which meet the aims of the NHS Long Term Plan.

Dr Lucy Thomas, Consultant Dermatologist at Chelsea & Westminster Hospital, said: “Skin Analytics’ receipt of this award is great news for the NHS and dermatology departments. It will allow us to gather real-world data to demonstrate the benefits of AI on patient pathways and workforce challenges. 

"Like many services, dermatology has severe backlogs due to the COVID-19 pandemic. This award couldn't have come at a better time to aid recovery and give us more time with the patients most in need of our help.”

Share article